Ani Pharmaceuticals Stock Price Patterns
| ANIP Stock | USD 78.91 1.55 2.00% |
Momentum 44
Sell Extended
Oversold | Overbought |
Quarterly Earnings Growth (0.17) | EPS Estimate Next Quarter 2.0414 | EPS Estimate Current Year 7.521 | EPS Estimate Next Year 8.6444 | Wall Street Target Price 110.5 |
Using ANI Pharmaceuticals hype-based prediction, you can estimate the value of ANI Pharmaceuticals from the perspective of ANI Pharmaceuticals response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards ANI Pharmaceuticals using ANI Pharmaceuticals' stock options and short interest. It helps to benchmark the overall future attitude of investors towards ANI using crowd psychology based on the activity and movement of ANI Pharmaceuticals' stock price.
ANI Pharmaceuticals Short Interest
An investor who is long ANI Pharmaceuticals may also wish to track short interest. As short interest increases, investors should be becoming more worried about ANI Pharmaceuticals and may potentially protect profits, hedge ANI Pharmaceuticals with its derivative instruments, or be ready for some potential downside.
200 Day MA 79.3211 | Short Percent 0.1927 | Short Ratio 6.21 | Shares Short Prior Month 2.9 M | 50 Day MA 81.2832 |
ANI Pharmaceuticals Hype to Price Pattern
Investor biases related to ANI Pharmaceuticals' public news can be used to forecast risks associated with an investment in ANI. The trend in average sentiment can be used to explain how an investor holding ANI can time the market purely based on public headlines and social activities around ANI Pharmaceuticals. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of ANI Pharmaceuticals' market sentiment to its price can help taders to make decisions based on the overall investors consensus about ANI Pharmaceuticals.
ANI Pharmaceuticals Implied Volatility | 0.67 |
ANI Pharmaceuticals' implied volatility exposes the market's sentiment of ANI Pharmaceuticals stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if ANI Pharmaceuticals' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that ANI Pharmaceuticals stock will not fluctuate a lot when ANI Pharmaceuticals' options are near their expiration.
The fear of missing out, i.e., FOMO, can cause potential investors in ANI Pharmaceuticals to buy its stock at a price that has no basis in reality. In that case, they are not buying ANI because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
ANI Pharmaceuticals after-hype prediction price | USD 77.28 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current ANI contract
Based on the Rule 16, the options market is currently suggesting that ANI Pharmaceuticals will have an average daily up or down price movement of about 0.0419% per day over the life of the 2026-04-17 option contract. With ANI Pharmaceuticals trading at USD 78.91, that is roughly USD 0.033 . If you think that the market is fully incorporating ANI Pharmaceuticals' daily price movement you should consider acquiring ANI Pharmaceuticals options at the current volatility level of 0.67%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Check out ANI Pharmaceuticals Basic Forecasting Models to cross-verify your projections. ANI Pharmaceuticals After-Hype Price Density Analysis
As far as predicting the price of ANI Pharmaceuticals at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in ANI Pharmaceuticals or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of ANI Pharmaceuticals, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
ANI Pharmaceuticals Estimiated After-Hype Price Volatility
In the context of predicting ANI Pharmaceuticals' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on ANI Pharmaceuticals' historical news coverage. ANI Pharmaceuticals' after-hype downside and upside margins for the prediction period are 75.05 and 79.51, respectively. We have considered ANI Pharmaceuticals' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
ANI Pharmaceuticals is very steady at this time. Analysis and calculation of next after-hype price of ANI Pharmaceuticals is based on 3 months time horizon.
ANI Pharmaceuticals Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as ANI Pharmaceuticals is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading ANI Pharmaceuticals backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with ANI Pharmaceuticals, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.01 | 2.25 | 0.02 | 0.00 | 7 Events / Month | 2 Events / Month | In about 7 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
78.91 | 77.28 | 0.10 |
|
ANI Pharmaceuticals Hype Timeline
ANI Pharmaceuticals is presently traded for 78.91. The entity has historical hype elasticity of -0.02, and average elasticity to hype of competition of 0.0. ANI is forecasted to decline in value after the next headline, with the price expected to drop to 77.28. The average volatility of media hype impact on the company price is about 109.76%. The price decrease on the next news is expected to be -0.1%, whereas the daily expected return is presently at 0.01%. The volatility of related hype on ANI Pharmaceuticals is about 1642.34%, with the expected price after the next announcement by competition of 78.91. About 98.0% of the company shares are held by institutions such as insurance companies. The book value of ANI Pharmaceuticals was presently reported as 24.19. The company has Price/Earnings To Growth (PEG) ratio of 1.06. ANI Pharmaceuticals had not issued any dividends in recent years. The entity had 1:6 split on the 18th of July 2013. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out ANI Pharmaceuticals Basic Forecasting Models to cross-verify your projections.ANI Pharmaceuticals Related Hype Analysis
Having access to credible news sources related to ANI Pharmaceuticals' direct competition is more important than ever and may enhance your ability to predict ANI Pharmaceuticals' future price movements. Getting to know how ANI Pharmaceuticals' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how ANI Pharmaceuticals may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| HROW | Harrow Health | 1.61 | 6 per month | 2.66 | 0.13 | 9.67 | (4.79) | 21.82 | |
| CASBF | CanSino Biologics | 0.00 | 0 per month | 0.00 | (0.14) | 0.00 | (3.60) | 16.88 | |
| BGM | Qilian International Holding | 0.07 | 3 per month | 0.00 | (0.39) | 5.68 | (16.71) | 49.57 | |
| TLRY | Tilray Inc | (0.31) | 9 per month | 0.00 | (0.07) | 7.64 | (8.43) | 54.17 | |
| DMPHF | Dermapharm Holding SE | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| HTSUF | Hisamitsu Pharmaceutical Co | 0.00 | 0 per month | 0.00 | 0.23 | 17.37 | (10.40) | 2.63 | |
| GTBIF | Green Thumb Industries | 0.00 | 0 per month | 5.32 | 0.01 | 10.59 | (7.24) | 67.92 | |
| TSMRF | Tsumura Co | 0.00 | 0 per month | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| TCNNF | Trulieve Cannabis Corp | 0.00 | 0 per month | 6.03 | 0.02 | 13.73 | (10.82) | 89.76 | |
| ARSUF | Fagron NV | 0.00 | 0 per month | 0.00 | 0.08 | 0.00 | 0.00 | 17.11 |
ANI Pharmaceuticals Additional Predictive Modules
Most predictive techniques to examine ANI price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for ANI using various technical indicators. When you analyze ANI charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About ANI Pharmaceuticals Predictive Indicators
The successful prediction of ANI Pharmaceuticals stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as ANI Pharmaceuticals, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of ANI Pharmaceuticals based on analysis of ANI Pharmaceuticals hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to ANI Pharmaceuticals's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to ANI Pharmaceuticals's related companies. | 2023 | 2024 | 2025 | 2026 (projected) | Dividend Yield | 0.001637 | 0.001522 | 0.00137 | 0.001194 | Price To Sales Ratio | 2.04 | 1.74 | 2.0 | 1.9 |
Pair Trading with ANI Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ANI Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ANI Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.Moving against ANI Stock
| 0.44 | RO | Roche Holding AG | PairCorr |
| 0.44 | RHO6 | Roche Holding | PairCorr |
| 0.41 | TEV | Teva Pharmaceutical | PairCorr |
| 0.4 | VTRS | Viatris Aggressive Push | PairCorr |
| 0.37 | BRM | Bristol Myers Squibb | PairCorr |
| 0.35 | H6D | Haleon PLC Earnings Call Next Week | PairCorr |
The ability to find closely correlated positions to ANI Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ANI Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ANI Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ANI Pharmaceuticals to buy it.
The correlation of ANI Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ANI Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ANI Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ANI Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ANI Stock Analysis
When running ANI Pharmaceuticals' price analysis, check to measure ANI Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ANI Pharmaceuticals is operating at the current time. Most of ANI Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of ANI Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ANI Pharmaceuticals' price. Additionally, you may evaluate how the addition of ANI Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.